Abstract
Background Previous research has shown that articles may be cited more frequently on the basis of title or abstract positivity. Whether a similar selective sharing practice exists on Twitter is not well understood. The objective of this study was to assess if COVID-19 articles with positive titles or abstracts were tweeted more frequently than those with non-positive titles or abstracts.
Methods COVID-19 related articles published between January 1st and April 14th, 2020 were extracted from the LitCovid database and all articles were screened for eligibility. Titles and abstracts were classified using a list of positive and negative words from a previous study. A negative binomial regression analysis controlling for confounding variables (2018 impact factor, open access status, continent of the corresponding author, and topic) was performed to obtain regression coefficients, with the p values obtained by likelihood ratio testing.
Results A total of 3752 COVID-19 articles were included. Of the included studies, 44 titles and 112 abstracts were positive; 1 title and 7 abstracts were negative; and 3707 titles and 627 abstracts were neutral. Articles with positive titles had a lower tweet rate relative to articles with non-positive titles, with a regression coefficient of -1.10 (P < .001), while the positivity of the abstract did not impact tweet rate (P = .2218).
Conclusion COVID-19 articles with non-positive titles are preferentially tweeted, while abstract positivity does not influence tweet rate.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no funding provided for this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research ethics board approval for this type of research is waived at the University of Ottawa.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(nfabi026{at}uottawa.ca) (Joint first-authorship)
(zhall031{at}uottawa.ca) (Joint first-authorship)
(swong021{at}uottawa.ca)
(jsalameh{at}toh.ca)
(skazi036{at}uottawa.ca)
(aunni019{at}uottawa.ca)
(ltrea080{at}uottawa.ca)
(rfran048{at}uottawa.ca)
(rprager{at}toh.ca)
Data Availability
The pre-specified study protocol is available at the following link https://osf.io/5wvjq/